Polymorphism in the Promoter Region of the β-Fibrinogen Gene and Fibrinogen Plasma Levels in an In-Patient Population

Thromb Haemost 1994; 72(02): 325-326
DOI: 10.1055/s-0038-1648862

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

A Palmeiro

¹Laboratório de Hematologia, Hospitais da Universidade de Coimbra, Portugal
J Carvalho-Sousa

²Serviço de Patologia Clinica, Faculdade de Medicina de Lisboa, 1600 Lisboa, Portugal
C Ferrer-Antunes

¹Laboratório de Hematologia, Hospitais da Universidade de Coimbra, Portugal

References
1 Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiology study on factor VII, factor VIII, and fibrinogen in an industrial population:I. Baselinedata on the relation to age, gender, body weight, smoking, alcohol, pill using and menopause. Thromb Haemost 1985; 54: 475-479
2 Bonnar J. Haemostasis in pregnancy and coagulation disorders. In: ScientificBasis of Obstetrics and Gynaecology MacDonald RR. (ed) Edinburgh: Churchill Livingstone; 1978. pp 249-273
3 Fey GH, Fuller GM. Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 1987; 258: 1183-1186
4 Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; i 1452-1455
5 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the (3 fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65 (05) 487-490